Market Research Logo

Generics in Brazil

Generics in Brazil

Summary

Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Brazil generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The Brazilian generics market had total revenues of $6.4bn in 2017, representing a compound annual growth rate (CAGR) of 10.7% between 2013 and 2017.
  • Market consumption volume increased with a CAGR of 4.7% between 2013 and 2017, to reach a total of 32.8% in 2017.
  • The percentage use of generics in terms of the total market is low when compared to countries in North America but is growing quickly due to government efforts.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the Brazil generics market by value in 2017?
  • What will be the size of the Brazil generics market in 2022?
  • What factors are affecting the strength of competition in the Brazil generics market?
  • How has the market performed over the last five years?
  • How large is Brazil’s generics market in relation to its regional counterparts?


Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Ache Laboratorios Farmaceuticos SA
EMS SA
Eurofarma Laboratorios SA
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Brazil generics market value: $ million, 2013-17
Table 2: Brazil generics market volume: % of total pharma, 2013-17
Table 3: Brazil generics market geography segmentation: $ million, 2017
Table 4: Brazil generics market value forecast: $ million, 2017-22
Table 5: Brazil generics market volume forecast: % of total pharma, 2017-22
Table 6: Ache Laboratorios Farmaceuticos SA: key facts
Table 7: EMS SA: key facts
Table 8: Eurofarma Laboratorios SA: key facts
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: key financials ($)
Table 11: Sanofi SA: key financials (€)
Table 12: Sanofi SA: key financial ratios
Table 13: Brazil size of population (million), 2013-17
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2013-17
Table 15: Brazil gdp (current prices, $ billion), 2013-17
Table 16: Brazil inflation, 2013-17
Table 17: Brazil consumer price index (absolute), 2013-17
Table 18: Brazil exchange rate, 2013-17
List of Figures
Figure 1: Brazil generics market value: $ million, 2013-17
Figure 2: Brazil generics market volume: % of total pharma, 2013-17
Figure 3: Brazil generics market geography segmentation: % share, by value, 2017
Figure 4: Brazil generics market value forecast: $ million, 2017-22
Figure 5: Brazil generics market volume forecast: % of total pharma, 2017-22
Figure 6: Forces driving competition in the generics market in Brazil, 2017
Figure 7: Drivers of buyer power in the generics market in Brazil, 2017
Figure 8: Drivers of supplier power in the generics market in Brazil, 2017
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2017
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2017
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2017
Figure 12: Sanofi SA: revenues & profitability
Figure 13: Sanofi SA: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report